Concepedia

Publication | Closed Access

Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248

DOI

189

Citations

27

References

2007

Year

Steven P. Treon, Zachary R. Hunter, Jeffrey Matous, Robin Joyce, Brian Mannion, Ranjana H. Advani, David Cook, J. Glenn Songer, John M. Hill, Bruce R. Kaden,
Clinical Cancer Research

Abstract

The results of these studies show that bortezomib is an active agent in relapsed and refractory WM.

References

YearCitations

Page 1